Cargando…

New insights into Shiga toxin-mediated endothelial dysfunction in hemolytic uremic syndrome

Shiga toxin-producing E. coli represents a significant global health concern, especially as hypervirulent pathogens surface amidst outbreaks of hemolytic uremic syndrome (HUS). Shiga toxin (Stx) is key in the microangiopathic events underlying the disease and its central role is underscored by the u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Petruzziello-Pellegrini, Tania N, Moslemi-Naeini, Mozhgan, Marsden, Philip A
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2013
Materias:	Special Focus Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5359733/ https://www.ncbi.nlm.nih.gov/pubmed/23955166 http://dx.doi.org/10.4161/viru.26143

Ejemplares similares

Shiga Toxins and the Pathophysiology of Hemolytic Uremic Syndrome in Humans and Animals
por: Mayer, Chad L., et al.
Publicado: (2012)

Shiga Toxin-Mediated Hemolytic Uremic Syndrome: Time to Change the Diagnostic Paradigm?
por: Bielaszewska, Martina, et al.
Publicado: (2007)

Treatment and outcome of Shiga-toxin-associated hemolytic uremic syndrome (HUS)
por: Scheiring, Johanna, et al.
Publicado: (2008)

Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review
por: Joseph, Adrien, et al.
Publicado: (2020)

Shiga toxin-associated hemolytic uremic syndrome complicated by intestinal perforation in a child with typical hemolytic uremic syndrome
por: Chang, Hye Jin, et al.
Publicado: (2014)

Complement Activation Contributes to the Pathophysiology of Shiga Toxin-Associated Hemolytic Uremic Syndrome
por: Buelli, Simona, et al.
Publicado: (2019)

Shiga Toxin–Associated Hemolytic Uremic Syndrome in Adults, France, 2009–2017
por: Travert, Benoît, et al.
Publicado: (2021)

Hemolytic uremic syndrome with simultaneous Shiga toxin producing Escherichia coli and complement abnormalities
por: McCoy, Nicole, et al.
Publicado: (2014)

Epidemiology and Characterization of Shiga Toxin-Producing Escherichia Coli of Hemolytic Uremic Syndrome in Argentina
por: Torti, Jeronimo F, et al.
Publicado: (2021)

Diagnosis and Treatment for Shiga Toxin-Producing Escherichia coli Associated Hemolytic Uremic Syndrome
por: Liu, Yang, et al.
Publicado: (2022)

First Shiga Toxin-Producing Escherichia coli Isolate from a Patient with Hemolytic Uremic Syndrome, Brazil
por: Guth, Beatriz Ernestina C., et al.
Publicado: (2002)

Valid Presumption of Shiga Toxin-Mediated Damage of Developing Erythrocytes in EHEC-Associated Hemolytic Uremic Syndrome
por: Detzner, Johanna, et al.
Publicado: (2020)

Combined Action of Shiga Toxin Type 2 and Subtilase Cytotoxin in the Pathogenesis of Hemolytic Uremic Syndrome
por: Álvarez, Romina S., et al.
Publicado: (2021)

Hemoconcentration and predictors in Shiga toxin-producing E. coli-hemolytic uremic syndrome (STEC-HUS)
por: Loos, Sebastian, et al.
Publicado: (2021)

Shiga Toxin–Producing Escherichia coli Infections Associated with Hemolytic Uremic Syndrome, Italy, 1988–2000
por: Tozzi, Alberto E., et al.
Publicado: (2003)

Shiga toxin producing Escherichia coli-associated diarrhea and hemolytic uremic syndrome in young children in Romania
por: Falup-Pecurariu, Oana, et al.
Publicado: (2019)

Heme as Possible Contributing Factor in the Evolvement of Shiga-Toxin Escherichia coli Induced Hemolytic-Uremic Syndrome
por: Wijnsma, Kioa L., et al.
Publicado: (2020)

Whole-genome characterization of hemolytic uremic syndrome-causing Shiga toxin-producing Escherichia coli in Sweden
por: Hua, Ying, et al.
Publicado: (2021)

Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management
por: Travert, Benoit, et al.
Publicado: (2021)

Heparin-induced thrombocytopenia following Shiga-toxin-associated hemolytic uremic syndrome: a case report
por: Rigamonti, Elia, et al.
Publicado: (2022)

Cardiovascular impairment in Shiga-toxin-2-induced experimental hemolytic–uremic syndrome: a pilot study
por: Neu, Charles, et al.
Publicado: (2023)

Shiga Toxin 2 Triggers C3a-Dependent Glomerular and Tubular Injury through Mitochondrial Dysfunction in Hemolytic Uremic Syndrome
por: Buelli, Simona, et al.
Publicado: (2022)

Activation of the Nlrp3 Inflammasome Contributes to Shiga Toxin-Induced Hemolytic Uremic Syndrome in a Mouse Model
por: Song, Liqiong, et al.
Publicado: (2021)

Severe Neurological Involvement in an Adult with Shiga Toxin-Producing Escherichia coli-Hemolytic Uremic Syndrome Treated with Eculizumab
por: Vanesse, Pauline, et al.
Publicado: (2023)

Sporadic Shiga Toxin–Producing Escherichia coli–Associated Pediatric Hemolytic Uremic Syndrome, France, 2012–2021
por: Jones, Gabrielle, et al.
Publicado: (2023)

Hemolytic uremic syndrome due to shiga-like toxin producing Escherichia coli 048:H21 in South Australia.
por: Goldwater, P N, et al.
Publicado: (1995)

Hemolytic Uremic Syndrome Associated with Escherichia coli O8:H19 and Shiga Toxin 2f Gene
por: Friesema, Ingrid H.M., et al.
Publicado: (2015)

Soluble CD40 Ligand and Oxidative Response Are Reciprocally Stimulated during Shiga Toxin-Associated Hemolytic Uremic Syndrome
por: Abrey Recalde, Maria J., et al.
Publicado: (2017)

Hemolytic uremic syndrome caused by Shiga toxin–producing Escherichia coli in children: incidence, risk factors, and clinical outcome
por: Ylinen, Elisa, et al.
Publicado: (2020)

Hemolytic uremic syndrome caused by Shiga toxin-producing Escherichia coli in a renal transplant recipient case report
por: Nieto-Rios, John Fredy, et al.
Publicado: (2020)

Hemolytic Uremic Syndrome: Toxins, Vessels, and Inflammation
por: Cheung, Victoria, et al.
Publicado: (2014)

Antibody Response to Shiga Toxins in Argentinean Children with Enteropathic Hemolytic Uremic Syndrome at Acute and Long-Term Follow-Up Periods
por: Fernández-Brando, Romina J., et al.
Publicado: (2011)

Shiga Toxin and Lipopolysaccharide Induce Platelet-Leukocyte Aggregates and Tissue Factor Release, a Thrombotic Mechanism in Hemolytic Uremic Syndrome
por: Ståhl, Anne-lie, et al.
Publicado: (2009)

An Atypical Case of Shiga Toxin Producing-Escherichia Coli Hemolytic and Uremic Syndrome (STEC-HUS) in a Lung Transplant Recipient
por: Manière, Louis, et al.
Publicado: (2019)

Gut–Kidney Axis on Chip for Studying Effects of Antibiotics on Risk of Hemolytic Uremic Syndrome by Shiga Toxin-Producing Escherichia coli
por: Lee, Yugyeong, et al.
Publicado: (2021)

1098. Clinical Features and Outcomes of United States Marine Corps Recruits Hospitalized With Shiga Toxin-Producing Escherichia coli Infection and Hemolytic–Uremic Syndrome
por: Sanders, Terrel, et al.
Publicado: (2018)

Therapeutic use of a receptor mimic probiotic reduces intestinal Shiga toxin levels in a piglet model of hemolytic uremic syndrome
por: Hostetter, Shannon J, et al.
Publicado: (2014)

Humoral immune response to Shiga Toxin 2 (Stx2) among Brazilian urban children with hemolytic uremic syndrome and healthy controls
por: Guirro, Mirian, et al.
Publicado: (2014)

Circulating microRNAs in Patients with Shiga-Toxin-Producing E. coli O104:H4 Induced Hemolytic Uremic Syndrome
por: Lorenzen, Johan M., et al.
Publicado: (2012)

LPS-primed CD11b(+) leukocytes serve as an effective carrier of Shiga toxin 2 to cause hemolytic uremic syndrome in mice
por: Niu, Shuo, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_63bb9mkjo4cc717ki1sfcvj557